http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2111963-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4655b70cbfba352025a1d2393b449e77
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-02
filingDate 1993-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1998-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c660f80987f981a94f70ce5e093b09fe
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_82d47e3851d9c6915e766c54b97af0e4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e6fde39f988444143b75487f1e59c55b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2176abe0832fd345ca356470a34029ee
publicationDate 1998-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2111963-C1
titleOfInvention 2-amino-n- [4-(aminocarbonyl)pyrimidin-2-yl] amino-alkyl pyrimidine-4-carboxamide derivatives, and pharmaceutical composition
abstract FIELD: pharmaceutical industry. SUBSTANCE: present invention describes compounds of general formula I given in the specification wherein m is 0 or 1, R 1 is methyl group, R 2 is phenoxy C 1 -C 4 alkyl group or R 1 and R 2 form together, and with nitrogen atom attached to them, 4- phenoxypiperidin -1-yl group, phenoxymethylpiperidin-1-yl group or 4-phenyl piperazin - 1-yl group, and R 3 is hydrogen atom, and only when n is 1, hydroxy group or methoxy group. EFFECT: improved properties of the pharmaceutical composition. 7 cl, 2 tbl
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2771326-C2
priorityDate 1992-07-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396401
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396411
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393787
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421359150
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412405262
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412405268
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10129899
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID77922
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394858
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420474345
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID429393030
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID424383334
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454463664
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12146
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439260
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19013279
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538190
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407182981
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6041
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419504954
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419646300
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9928781
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413615359
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54522065
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19013273
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420574205
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535600
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396945
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID17861762
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID236409
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457444288
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID153888279
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1030
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID247028
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421005704
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415901103
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18980287
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415893423
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416290180
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457501988
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4737
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID97629
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15149799
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22285356
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421014960
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393705
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5814
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458395052
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419544741

Total number of triples: 87.